Stamford, CT -- (SBWIRE) -- 01/27/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: BioDelivery Sciences International, Inc. (NASDAQ:BDSI), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Synaptics, Incorporated (NASDAQ:SYNA), Vringo, Inc. (NASDAQ:VRNG)
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) opened the session at $8.95, trading in a range of $8.18 - $9.49. The stock showed a positive performance of +50.56% in the last trading session from its previous close of $6.25 and closed at $9.41. The stock traded on a volume of 14.99 million shares and the average volume of the stock remained 940,551 shares. BioDelivery Sciences International, Inc. (BDSI) is a specialty pharmaceutical company. BDSI is developing and commercializing, either on its own or in partnerships with third parties, applications of therapeutics to address medical needs. The Company has developed and is continuing to develop pharmaceutical products aimed principally in the areas of pain management and oncology supportive care.
For How Long BDSI will Fight for Profitability? Read This Trend Analysis report
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) traded 134.47 million shares in the last business day while the average volume of the stock remained 34.59 million shares. The stock showed a positive movement of +19.55% to end at $8.99. The 52 week range of the stock remained $2.15 - $23.00. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia that is resistant or intolerant to prior TKI therapy.
For How Long ARIA’s Gloss will Attract Investors? Find out via this report
Synaptics, Incorporated (NASDAQ:SYNA) reported 4.51 million shares were exchanged during the last trade, while the average volume is about 1.08 million shares. The stock escalated +6.07% and finished the day at $60.26. The beta of the stock is recorded at 1.09. Synaptics Incorporated is a developer and supplier of custom-designed human interface solutions that enable people to interact with a range of mobile computing, communications, entertainment, and other electronic devices. The Company focuses on the personal computer ( PC) market, primarily notebook computers, including ultrabooks, the markets for digital lifestyle products, including mobile smartphones and feature phones, the tablet market, and other select electronic device markets with its customized human interface solutions.
For How Long SYNA’s Gloss will Attract Investors? Find out via this report
Vringo, Inc. (NASDAQ:VRNG) shares rose, +5.09 percent from its previous close of $3.73 to close at $3.92. Traded with volume of 4.18 million shares in the prior session and the average volume of the stock remained 2.03 million shares. Vringo, Inc. (Vringo) is a development-stage company. The Company is engaged in developing software for mobile phones. It provides a platform, which allows users to create, download and share mobile entertainment content in the form of video ringtones for mobile phones. Vringo’s product consists of four components, such as The Vringo Mobile Application, The Vringo WAP Site, The Vringo Website and The Vringo Studio.
Why Should Investors Buy VRNG After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)